We would like to inform you that Board of Director of the Company has approved the sale and transfer of the equity shares of Otsuka Pharmaceutical India Private Limited (formerly knowns as Claris Otsuka Private Limited) held by Claris Lifesciences Limited (CLL') in its meeting held on May 8, 2017 to Otsuka Pharmaceutical Factory, Inc for a consideration of USD 20 million. A Press Release being issued in this regards is enclosed, request you to take the above information on your record.